Neurointerventional Microcatheters Set for Price Cut Starting August 1 Amid Provincial Alliance Tender

01

Class I High-Value Consumables

Effective from August 1

Image source: Guizhou Provincial Healthcare Security Administration

The volume-based procurement project to be implemented in Guizhou Province is led by Zhejiang Province.Centralized Procurement of Peripheral Vascular Interventional Microcatheter Consumables, procurement categories includePeripheral Vascular Interventional Microcatheters and Neurointerventional Therapy Microcatheters. The relevant information regarding microcatheters for neurointerventional therapy is as follows; it is noteworthy that the maximum effective declared price includes related costs such as delivery, delivery of ancillary tools, use of ancillary tools, and accompanying service fees.

Source: Zhejiang Provincial Medical Security Bureau

Peripheral Vascular Interventional Microcatheter ConsumablesA total of 29 provinces participated, all regions in Southwest China participated in this inter-provincial alliance centralized procurement, specifically including Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, Hubei, Hunan, Guangxi, Hainan, Chongqing, Sichuan, Guizhou, Yunnan, Tibet, Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang, and the Xinjiang Production and Construction Corps.

On May 7, the Zhejiang Provincial Medical Insurance Bureau announced the selection results for this category of medical consumables.A total of 47 companies and 102 neurointerventional microcatheter consumables were selected.In terms of the number of selected companies, domestic medical device manufacturers are relatively more numerous, but foreign companies such as Johnson & Johnson and Stryker also have multiple products shortlisted.

Image source: Zhejiang Provincial Healthcare Security Administration

According to the “Notice,”Guizhou will implement the selected bid results starting August 1, with a procurement cycle of three years.。

02

A Multi-Billion Market

How to Break the Import-Dominated Landscape

The market for neurointerventional devices, to which neurointerventional microcatheters belong, has experienced explosive growth in recent years. According to public data,The Market Size of Neurointerventional Devices in China Will Rise to 12.8 Billion Yuan in 2025, and is expected to maintain a trend of rapid growth. The core drivers fueling this market’s robust expansion include population aging, rising incidence of stroke, and increasing surgical penetration rates, among other factors.

However, this rapidly growing marketCurrently still dominated by foreign brandsAt this stage, the market share of neurointerventional procedures in China remains predominantly concentrated among foreign brands such as Medtronic, Stryker, and Johnson & Johnson. This trend is also evident from the procurement demand data recently released by Zhejiang Province, where the top three suppliers for microcatheters used in neurointerventional therapy are all foreign medical device companies.Covidien (acquired by Medtronic in 2015): 116,460 units; Stryker: 67,233 units; Johnson & Johnson: 26,174 units, with imports playing a dominant role and domestic brands accounting for a relatively small share.

In terms of microcatheter categories, currently240 products have been launched in China, among whichThe proportion of domestically produced products has reached 75.83%.. However, it is worth noting that Boston Scientific ranks first in the microcatheter category, and the top five are predominantly occupied by foreign medical device companies.

Image Source: Yaozhi Medical Device Data

This pattern is evident across multiple subsectors of neurointervention, such as coils and intracranial stents, where foreign brands have long dominated the technological high ground and market share, necessitating an acceleration in the substitution of domestic products for imports.

Under the comprehensive coverage of centralized procurement, neurointerventional consumables have been frequently included in the centralized procurement programs carried out by various provinces and municipalities, leading to a sharp decline in prices. Taking microcatheters as an example,Yaozhi Medical Device Data has indexed 49,106 volume-based procurement records., including 73 winning bidders, with the average price reduction for various types of consumables exceeding 50%. This time, as the “mini-national procurement” for neurointerventional microcatheters, led by Zhejiang Province, is successively implemented in multiple provinces, it will trigger a wave of price reductions across a wide range of regions in China.

03

Conclusion

The Full Implementation of Centralized Procurement for Neurointerventional Microcatheters Marks the Entry of This High-Value Consumables Sector into a Normalized Phase of Centralized Procurement. Although the Market Is Currently Dominated by Foreign Brands, the Process of Domestic Substitution and Industry Consolidation Will Continue to Accelerate as Chinese Medical Device Manufacturers Intensify Their Efforts.

Disclaimer: This content is intended solely for the dissemination of information within the medical device industry. It represents the author’s independent views and does not reflect the position of Yaozhi Medical Devices. For any reprints, please clearly cite the author and source. If you have any objections or complaints regarding this article, please contact maxuelian@yaozh.com.

Responsible Editor |Kapok

Collaboration, Submission, Reproduction Permission |Teacher Ma 18323856316 (WeChat same)